TOULOUSE, France, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Cell-Easy, a specialized contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs.
The new "consortium" and their multi-disciplinary teams offers a strategic advantage for Biotechs/Pharmas looking to expedite the implementation of innovative clinical studies. The geographical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results